TEVA PHARMS USA FDA Approval ANDA 212485

ANDA 212485

TEVA PHARMS USA

FDA Drug Application

Application #212485

Documents

Letter2019-12-04

Application Sponsors

ANDA 212485TEVA PHARMS USA

Marketing Status

None (Tentative Approval)001

Application Products

001LOTION;TOPICAL0.5%0IVERMECTINIVERMECTIN

FDA Submissions

UNKNOWN; ORIG1TA2019-11-19STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

TEVA PHARMS USA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212485
            [companyName] => TEVA PHARMS USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"IVERMECTIN","activeIngredients":"IVERMECTIN","strength":"0.5%","dosageForm":"LOTION;TOPICAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/19\/2019","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/212485Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-11-19
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.